The Relationship Between Fracture and Mortality in a Chinese Maintenance Hemodialysis Patients Cohort

Overview

Journal J Multidiscip Healthc

Publisher Dove Medical Press

Specialty Health Services

Date 2024 May 6

PMID 38706503

Authors

Xi Liu

Zhonghan Liu

Yangyang Niu

Kun Zhang

Xiaoqin Zhang

Chen Yu

Affiliations

Soon will be listed here.

Abstract

Background: Patients on maintenance hemodialysis have an increased risk of fracture. However, the relationship between fracture and poor prognosis is not clear.

Methods: A total of 182 maintenance hemodialysis patients were enrolled in the study. The relationship between fracture and poor prognosis (cardiovascular events, stroke, malignancy and 5-year all-cause mortality) were analyzed.

Results: 21 of 182 patients had a history of fracture at the time of enrollment. 26 patients had a new fracture after enrollment. A total of 57 fractures occurred in 47 patients, the most common fracture site was the rib. Patients with fracture group had a higher proportion of elderly and female, higher serum phosphorus and B-type natriuretic peptide and lower hemoglobin, albumin, and potassium compared with those without fracture. Age (), hemoglobin (), and serum phosphorus () were the independent risk factors of new fractures in MHD patients. The incidence of malignancy and 5-year all-cause mortality in patients with fracture was higher than those without fracture (). But there was no significant difference in the incidence of acute myocardial infarction or stroke.

Conclusion: 25.8% of maintenance hemodialysis patients had at least one fracture, with rib fractures accounting for the highest proportion. Age, hemoglobin and serum phosphorus were the independent risk factors of new fractures. The incidence of malignancy and 5-year all-cause mortality in patients with fracture was higher than those without fracture, but there was no significant difference in the incidence of acute myocardial infarction and stroke.

References

Tentori F, McCullough K, Kilpatrick R, Bradbury B, Robinson B, Kerr P . High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney Int. 2013; 85(1):166-73. PMC: 3910091. DOI: 10.1038/ki.2013.279. View

Barrera-Baena P, Rodriguez-Garcia M, Rodriguez-Rubio E, Gonzalez-Llorente L, Ortiz A, Zoccali C . Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients. Nephrol Dial Transplant. 2023; 39(4):618-626. PMC: 10966329. DOI: 10.1093/ndt/gfad190. View

Wang L, Xu X, Zhang M, Hu C, Zhang X, Li C . Prevalence of Chronic Kidney Disease in China: Results From the Sixth China Chronic Disease and Risk Factor Surveillance. JAMA Intern Med. 2023; 183(4):298-310. PMC: 9941971. DOI: 10.1001/jamainternmed.2022.6817. View

Kwon S, Han J, Kim H, Kang G, Kang M, Kim Y . The Incidences and Characteristics of Various Cancers in Patients on Dialysis: a Korean Nationwide Study. J Korean Med Sci. 2019; 34(25):e176. PMC: 6597487. DOI: 10.3346/jkms.2019.34.e176. View

Kwon Y, Choi H, Oh H, Ahn S, Ryu D, Kwon Y . Vertebral fracture is associated with myocardial infarction in incident hemodialysis patients: a Korean nationwide population-based study. Osteoporos Int. 2020; 31(10):1965-1973. DOI: 10.1007/s00198-020-05423-y. View

Iseri K, Carrero J, Evans M, Runesson B, Stenvinkel P, Lindholm B . Secular trends in hip fracture incidence and subsequent mortality in dialysis patients and the general population in Sweden. Bone. 2021; 147:115909. DOI: 10.1016/j.bone.2021.115909. View

Fusaro M, Holden R, Lok C, Iervasi G, Plebani M, Aghi A . Phosphate and bone fracture risk in chronic kidney disease patients. Nephrol Dial Transplant. 2019; 36(3):405-412. DOI: 10.1093/ndt/gfz196. View

Pyrza M, Glogowski T, Wieliczko M, Zebrowski P, Ewa W, Semeniuk-Wojtas A . Malignancy Prevalence in the Dialyzed Population and in Waitlisted Potential Kidney Transplant Recipients. Transplant Proc. 2022; 54(4):930-933. DOI: 10.1016/j.transproceed.2022.01.025. View

Rasmussen N, Sarodnik C, Bours S, Schaper N, Souverein P, Jensen M . The pattern of incident fractures according to fracture site in people with T1D. Osteoporos Int. 2021; 33(3):599-610. DOI: 10.1007/s00198-021-06175-z. View

10.

Maezawa K, Nozawa M, Maruyama Y, Sakuragi E, Sugimoto M, Ishijima M . Comparison of anemia, renal function, and nutritional status in older women with femoral neck fracture and older women with osteoarthritis of the hip joint. J Orthop Sci. 2022; 28(2):380-384. DOI: 10.1016/j.jos.2021.12.009. View

11.

Wakasugi M, Kazama J, Wada A, Hamano T, Masakane I, Narita I . Hip Fracture Trends in Japanese Dialysis Patients, 2008-2013. Am J Kidney Dis. 2017; 71(2):173-181. DOI: 10.1053/j.ajkd.2017.07.017. View

12.

Sofue T, Nakagawa N, Kanda E, Nagasu H, Matsushita K, Nangaku M . Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLoS One. 2020; 15(7):e0236132. PMC: 7371174. DOI: 10.1371/journal.pone.0236132. View

13.

Floege J, Tsirtsonis K, Iles J, Drueke T, Chertow G, Parfrey P . Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. Kidney Int. 2018; 93(6):1475-1482. DOI: 10.1016/j.kint.2017.12.014. View

14.

Gonzalez-Parra E, Bover J, Herrero J, Sanchez E, Molina P, Martin-Malo A . Control of phosphorus and prevention of fractures in the kidney patient. Nefrologia (Engl Ed). 2022; 41(1):7-14. DOI: 10.1016/j.nefroe.2021.02.003. View

15.

Zhao X, Gan L, Niu Q, Hou F, Liang X, Chen X . Clinical Outcomes in Patients on Hemodialysis with Congestive Heart Failure. Kidney Dis (Basel). 2023; 9(4):306-316. PMC: 10601911. DOI: 10.1159/000529802. View

16.

Zhang L, Long J, Jiang W, Shi Y, He X, Zhou Z . Trends in Chronic Kidney Disease in China. N Engl J Med. 2016; 375(9):905-6. DOI: 10.1056/NEJMc1602469. View

17.

McCullough P . Phosphate Control: The Next Frontier in Dialysis Cardiovascular Mortality. Cardiorenal Med. 2021; 11(3):123-132. DOI: 10.1159/000516286. View

18.

Suresh S, Wright E, Wright D, Abbott K, Noguchi C . Erythropoietin treatment and the risk of hip fractures in hemodialysis patients. J Bone Miner Res. 2021; 36(7):1211-1219. PMC: 8360057. DOI: 10.1002/jbmr.4297. View

19.

Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T . Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial. JAMA. 2021; 325(19):1946-1954. PMC: 8132143. DOI: 10.1001/jama.2021.4807. View

20.

Alem A, Sherrard D, Gillen D, Weiss N, Beresford S, Heckbert S . Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000; 58(1):396-9. DOI: 10.1046/j.1523-1755.2000.00178.x. View